Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Gilead Sciences, Inc. (GILD) had Weighted-Average Shares Outstanding (Diluted) of 1.26B for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$7.11B |
|
$1.43B |
|
$2.09B |
|
$5.02B |
|
$5.50B |
|
$1.61B |
|
$40.00M |
|
$1.65B |
|
$1.65B |
|
$1.42B |
|
$1.42B |
|
$1.42B |
|
$1.42B |
|
$1.61B |
|
$2.30B |
|
1.25B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.26B |
$1.14 |
|
$1.14 |
|
| Balance Sheet Financials | |
$16.09B |
|
$5.32B |
|
$46.04B |
|
$62.12B |
|
$11.28B |
|
$24.47B |
|
$28.10B |
|
$39.38B |
|
$22.75B |
|
$-12.02B |
|
$22.75B |
|
1.25B |
|
| Cash Flow Statement Financials | |
$8.01B |
|
$-2.27B |
|
$-5.12B |
|
$5.41B |
|
$6.08B |
|
$673.00M |
|
$766.00M |
|
$-3.81B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.43 |
|
-- |
|
-- |
|
0.52 |
|
1.15 |
|
70.62% |
|
22.67% |
|
22.67% |
|
-- |
|
23.24% |
|
20.10% |
|
$7.42B |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
1.17 |
|
1.53 |
|
58.95 |
|
6.23% |
|
-11.79% |
|
2.28% |
|
3.00% |
|
$18.26 |
|
$5.90 |
|
$6.36 |
|